HVO Hvivo Plc

TIDMVENN

RNS Number : 9445H

Venn Life Sciences Holdings PLC

24 August 2016

24 August 2016

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Notice of results

Investor results presentation

Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that it will release its interim results for the six months ended 30 June 2016 on Wednesday 28 September 2016.

Analyst briefing

Tony Richardson, Chief Executive Officer and Jonathan Hartshorn Chief Financial Officer will be hosting a briefing for analysts on Wednesday 28 September 2016 at 10.30am at the offices of Walbrook PR, 4 Lombard St., London EC3V 9HD.

Investor briefing

The management team will also be presenting the Company's financial and operational results for investors on the evening of Wednesday 28 September 2016. The event is open to all investors and will be held at the Black Bar, upstairs at Rocket Bar 6 Adam's Court, Old Broad St, London EC2N 1DX.

To register to attend the analyst briefing or investor briefing, please contact Walbrook PR (details below).

 
 
Walbrook PR Limited    Tel: 020 7933 8780 or venn@walbrookpr.com 
Anna Dunphy                                   Mob: 07876 741 001 
Lianne Cawthorne                              Mob: 07584 391 303 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOREXLFLQVFLBBQ

(END) Dow Jones Newswires

August 24, 2016 02:01 ET (06:01 GMT)

Hvivo (LSE:HVO)
Historical Stock Chart
From Apr 2024 to May 2024

Hvivo (LSE:HVO)
Historical Stock Chart
From May 2023 to May 2024